
LAST PUBLICATIONS
The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk
Valdecantos MP, et al. Nat Commun. 2024 Nov 28;15(1):10342. doi: 10.1038/s41467-024-54080-w. PMID: 39609390´.
Time-restricted eating, the clock ticking behind the scenes.
Ribas-Latre A, et al. J. Front Pharmacol. 2024 Aug 8;15:1428601. doi: 10.3389/fphar.2024.1428601. eCollection 2024. PMID: 39175542
Mirasierra M, et al. Cell Mol Life Sci. 2024 Aug 12;81(1):343. doi: 10.1007/s00018-024-05384-z. PMID: 39129011
Sabadell-Basallote J, et al. J Clin Invest. 2024 May 7;134(12):e173214. doi: 10.1172/JCI173214. PMID: 38713514 Free PMC article.
Type 2 diabetes and succinate: unmasking an age-old molecule.
Fernández-Veledo S, et al. Diabetologia. 2024 Mar;67(3):430-442. doi: 10.1007/s00125-023-06063-7. Epub 2024 Jan 5. PMID: 38182909 Free PMC article.
The Diabetes and Metabolic Associated Diseases Research Group (DIAMET) is a multidisciplinary and dynamic research group focused on the study of metabolic derangements associated with diabetes mellitus and obesity morbidities.
The research group is led by Dr. Sonia Fernandez-Veledo and is composed by clinical and basic investigators, technicians and administrative support staff.
The group belongs to the Pere Virgili Institute (IISPV) and University Hospital from Tarragona Joan XXIII, and is integrated in a nationwide net for the study of diabetes, CIBERdem, that was initiated in 2008 by the Instituto de Salud Carlos III from Spain. Likewise, the group is recognised as a consolidated group by the Agencia de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) from the Generalitat de Catalunya since 2009, housed in the Rovira i Virgili University.
Funded by:
Address:
Hospital Universitari de Tarragona Joan XXIII
Edifici Modular de Docència i Recerca, Planta 1
C/Dr. Mallafré Guasch, 4
43007-Tarragona
Spain